Becton Dickinson and Company (BDX) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
Over the past 4 years, Becton Dickinson and Company has achieved a revenue compound annual growth rate (CAGR) of 3.4%, while earnings have grown at -5.4% CAGR.
Historical revenue and profitability trends for Becton Dickinson and Company
The chart above illustrates Becton Dickinson and Company's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Becton Dickinson and Company's business.
How efficiently Becton Dickinson and Company converts revenue into profit
Profit margins reveal how much of each dollar of revenue Becton Dickinson and Company retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Becton Dickinson and Company to continue growing earnings in the coming year. The consensus analyst rating is 3.5882 based on 17 analysts.
Based on our comprehensive analysis, Becton Dickinson and Company (BDX) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Becton Dickinson and Company's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Becton Dickinson and Company stacks up against similar companies
Explore growth analysis for top stocks
Related: BDX Valuation, BDX Dividend, BDX Financial Health
Compare: BDX vs AAPL, BDX vs MSFT, BDX vs GOOGL